Concepedia

Author

Ulf Aasebø

University Hospital of North Norway

Also Known As

J Vilsvik, S H Sundstrøm, U Aasebo, U Aasebø, U. AASEBø, U. Aasebo, U. Aasebø, ULF AASEBØ, Ulf Aasebo, Ulf Aasebø

80

Publications

3.4K

Citations

27

H-Index

63

Concepts

All Affiliations

University Hospital of North NorwayUiT The Arctic University of NorwayHaukeland University HospitalSt Olav's University HospitalNorwegian Cancer Society
UA

About

Ulf Aasebø is an author at University Hospital of North Norway specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

20

1.4K

2

Health Sciences

9

9

701

3

Public Health

1

1

29

4

Social Sciences

1

1

88

5

Allergy

1

1

34

Ulf Aasebø

×

41

Publications

3K

Citations

26

H-Index

YearCitations

Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up

Stein Sundstrøm, Roy M. Bremnes, Stein Kaasa,

Journal of Clinical Oncology

2002

501

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

Kazimierz Roszkowski, Maciej Krzakowski, A P Smith,

Lung Cancer

2000

308

Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Bjørn Henning Grønberg, Roy M. Bremnes, Øystein Fløtten,

Journal of Clinical Oncology

2009

289

The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up

Roy M. Bremnes, Stein Sundstrøm, Ulf Aasebø,

Lung Cancer

2003

191

Hypofractionated Palliative Radiotherapy (17 Gy per two fractions) in Advanced Non–Small-Cell Lung Carcinoma Is Comparable to Standard Fractionation for Symptom Control and Survival: A National Phase III Trial

Stein Sundstrøm, Roy M. Bremnes, Ulf Aasebø,

Journal of Clinical Oncology

2004

175

Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

Andreas Hermes, Bengt Bergman, Roy M. Bremnes,

Journal of Clinical Oncology

2008

166

Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial

Johan Svartberg, Ulf Aasebø, Audhild Hjalmarsen,

Respiratory Medicine

2004

111

Pulmonary Function in Long-Term Survivors of Testicular Cancer

Hege Sagstuen Haugnes, Nina Aass, Sophie D. Fosså,

Journal of Clinical Oncology

2009

94

Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy

Ulf Aasebø, Audhild Gyltnes, Roy M. Bremnes,

The Journal of Steroid Biochemistry and Molecular Biology

1993

88

Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer

Bjørn Henning Grønberg, Tarje Onsøien Halvorsen, Øystein Fløtten,

Acta Oncologica

2015

84

Page 1